Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

A new study links semaglutide, the active ingredient in Ozempic and Wegovy, to a higher risk of hair loss, especially in ...

A WOMAN has left ht internet stunned after losing 8 stone in just 9 months with Mounjaro. Jess, from the UK, says she is so ...

Just ask Tom Brady—arguably the greatest quarterback of all time. He doesn’t have the sculpted physique of a bodybuilder, yet ...

Global Partners LP (NYSE:GLP) reported a revenue of $4.19 billion in Q4 of 2024, missing estimates by $1.62 billion. EPS was ...

Student scientists have developed an incredible new way to synthesize drugs on plants — and they're using Ozempic as their ...

For years, people taking GLP-1 type drugs (e.g., Ozempic, Wegovy) have noticed that the medicines didn’t just help them to ...

In this week’s edition of InnovationRx, we look at the policy uncertainty around vaccines, sex differences in GLP-1 drug side ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

I asked a dietitian and nutritionist about the link between eating disorders and menopause, including the reasons for the ...

Viking Therapeutics ( VKTX -0.30%) is a promising growth stock with a strong GLP-1 drug candidate in VK2735, which may ...